Beyond Air, Inc.
XAIR Healthcare Medical Devices
Beyond Air, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $7.7 million, up 107.3% from fiscal 2025. In the quarter to June 2026, revenue was flat, EPS grew 64.1%, free cash flow fell 9.10% and total debt rose 127.3%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
Follow XAIR
Beyond Air, Inc. (XAIR) EV/Sales
As of 16 October 2026, Beyond Air, Inc. (XAIR) trades at a EV/Sales of 1.1×. Over the past ten years it has ranged from −1.4× (October 2024) to 382× (November 2021); the current reading is higher than 35% of that period. That is below the Medical Devices industry median of 2.2× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2026 | 1.4× | (76.03%) |
| FY2025 | 5.7× | (80.09%) |
| FY2024 | 28.7× | (63.61%) |
| FY2021 | 78.8× | 12.92% |
| FY2020 | 69.8× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.8× | 29.46% |
| Mar 2026 | 1.4× | (10.77%) |
| Dec 2025 | 1.5× | (37.12%) |
| Sep 2025 | 2.4× | (43.06%) |
| 18 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| IVF INVO Fertility, Inc compare | −0.3× |
| NUVOQ Holdco Nuvo Group D.G Ltd. compare | n/m |
| NUWE Nuwellis, Inc. compare | 0.0× |
| BIOLQ Biolase, Inc. compare | 0.3× |
| AFIB Acutus Medical, Inc. compare | 0.9× |
| XAIR Beyond Air, Inc. | 1.1× |
| VJET Flyte Aviation, Inc. compare | 2.1× |
| NXL Nexalin Technology, Inc. compare | 3.0× |
| ADGM Adagio Medical Holdings, Inc. compare | 32.1× |
| Medical Devices industry median | 2.2× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)